- Asia's development challenges are outpacing conventional funding models, with early-stage, high-risk innovations chronically underfunded
- Philanthropy Asia Alliance and Centre for Asian Philanthropy and Society's new research explores how Asian funders are bridging this gap, and the lessons to scale impact across the region
SINGAPORE - Media OutReach Newswire - 18 May 2026 - A new report released today at the sixth Philanthropy Asia Summit highlights what becomes possible when philanthropy in Asia is deployed as risk capital: funding that absorbs the risks of unproven solutions that governments are unable or unwilling to back, markets cannot yet price, and social innovators cannot bear alone. It also sets out what it will take to scale this approach and accelerate impact across the region.
The report spotlights 10 cases spanning climate, health, housing, water, waste, and digital inclusion where philanthropic risk capital underwrote the earliest and riskiest stages of social innovation. These range from sustainable housing and carbon removal technologies to public health interventions, with early backing helping solutions attract follow-on funding and achieve adoption within public systems. Collectively, these efforts have reached more than 210 million people across 13 Asian economies, a scale that demonstrates the model's potential, even as these cases represent only a small fraction of the region's needs.
"Philanthropy as Risk Capital in Asia: Bridging Innovation to Impact" was researched and written by the Centre for Asian Philanthropy and Society (CAPS) and commissioned by the Philanthropy Asia Alliance (PAA). Drawing on 10 case studies and 37 in-depth interviews with philanthropists, fund managers, social enterprise founders and programme leads across 13 markets, the report explores how and when Asian philanthropy functions as risk capital, and its potential to address development challenges in Asia at scale. It also examines what drives funders to take these risks, how capital is deployed across different instruments and stages of innovation, and the strategies used to manage risk while maximising impact.
Key findings
The findings point to several consistent patterns in how Asian philanthropists featured in the study approach early-stage risk:
SINGAPORE - Media OutReach Newswire - 18 May 2026 - A new report released today at the sixth Philanthropy Asia Summit highlights what becomes possible when philanthropy in Asia is deployed as risk capital: funding that absorbs the risks of unproven solutions that governments are unable or unwilling to back, markets cannot yet price, and social innovators cannot bear alone. It also sets out what it will take to scale this approach and accelerate impact across the region.
The report spotlights 10 cases spanning climate, health, housing, water, waste, and digital inclusion where philanthropic risk capital underwrote the earliest and riskiest stages of social innovation. These range from sustainable housing and carbon removal technologies to public health interventions, with early backing helping solutions attract follow-on funding and achieve adoption within public systems. Collectively, these efforts have reached more than 210 million people across 13 Asian economies, a scale that demonstrates the model's potential, even as these cases represent only a small fraction of the region's needs.
"Philanthropy as Risk Capital in Asia: Bridging Innovation to Impact" was researched and written by the Centre for Asian Philanthropy and Society (CAPS) and commissioned by the Philanthropy Asia Alliance (PAA). Drawing on 10 case studies and 37 in-depth interviews with philanthropists, fund managers, social enterprise founders and programme leads across 13 markets, the report explores how and when Asian philanthropy functions as risk capital, and its potential to address development challenges in Asia at scale. It also examines what drives funders to take these risks, how capital is deployed across different instruments and stages of innovation, and the strategies used to manage risk while maximising impact.
Key findings
The findings point to several consistent patterns in how Asian philanthropists featured in the study approach early-stage risk:
- Philanthropy as risk capital in Asia is often patient and conviction-driven; funders are prepared to commit long-term capital to enable solutions to scale. The largest and longest commitments came from individual philanthropists and families driven by personal conviction and direct experience of the challenges they seek to address. For example, The Tahija Foundation in Indonesia provided more than US$17 million over ten years to test a novel approach to dengue control using Wolbachia bacteria. A randomised controlled trial demonstrated a 77% reduction in dengue transmission, and the method has since been adopted into Indonesia's national health plan, with an estimated 14 million people now protected. Institutional funders complement this with more targeted, milestone-linked discipline and deep trust in founders.
- Funders are experimenting beyond traditional grants to explore a range of instruments across different growth stages. From concessional debt to equity, funders are exploring instruments across the spectrum, with some sequencing different forms of capital as trust and results develop over time. However, knowledge gaps and regulatory constraints in some markets continue to limit broader adoption.
- Funders are leveraging relationships, community trust and government access to manage risk and extend reach. They bring networks, credibility, and access to government stakeholders alongside capital, reducing implementation risk and laying the groundwork for long-term partnerships. The funder's proximity to the communities they serve, and alignment with domestic policy priorities, can prove as consequential as the funding itself.
- Funders are supporting alignment with public sector priorities from the outset, as early integration with public systems matters when government adoption is the pathway to scale. The projects that achieved the greatest reach did so through early engagement with government, with funders helping to align solutions with national or local priorities from the outset. For example, the Vanke Foundation made community waste management a thematic priority in support of China's zero-waste city ambitions, and backed INSPRO, a social enterprise using insect-based bioconversion to recycle organic waste. Beyond funding, the foundation facilitated access to district government stakeholders, enabling INSPRO to establish operations in Yantian and scale its technology for agricultural use. Similarly, Tata Trusts aligned its digital initiatives with the Government of India's Digital India programme, providing early-stage funding and ecosystem support to Haqdarshak, a platform improving access to government welfare schemes.
"For these Asian philanthropists deploying capital to support early-stage innovation, we observe how trust in the capabilities of the people behind the ideas is critical to managing these risks," says Dr. Ruth Shapiro, Co-Founder and CEO of CAPS. "And we see the importance of aligning with government as key to legitimacy and scale. The same strategies to manage risk are being leveraged to maximise impact for the community."
"The report highlights what makes early philanthropic capital unique," said Shaun Seow, CEO of PAA. "Taking an early position absorbs the risk of an untested solution and builds the evidence and regulatory confidence that later investment requires. PAA's role is to help connect funders across the region so those early commitments compound rather than sit in isolation."
Research methodology
The findings are based on a region-wide scan of social enterprises, programmes, and initiatives centred on novel or unproven solutions. Ten cases were selected through a targeted assessment identifying high-potential pathways for philanthropic risk capital across climate, health, and inclusive development. The research was conducted between October 2025 and January 2026, through 37 in-depth interviews and a review of academic and non-academic literature.
The cases examined include Agros, BillionBricks, Equatic, Haqdarshak, Inspro, Seven Clean Seas, Urban Spring, Wadhwani AI, Wateroam, and the World Mosquito Programme in Yogyakarta.
Download the full report: https://p-aa.org/PhilanthropyAsRiskCapitalReport (Live on 18 May)
The issuer is solely responsible for the content of this announcement.
About Philanthropy Asia Alliance (PAA)
Philanthropy Asia Alliance (PAA) is a Temasek Trust initiative dedicated to catalysing collaborative philanthropy in Asia through dynamic multi-sector partnerships. By harnessing collective strengths, PAA multiplies impact, accelerates positive change, and takes urgent action to address the pressing environmental and social challenges of our time. PAA's flagship programme is the annual Philanthropy Asia Summit. For more information, visit http://philanthropyasiaalliance.org
About the Centre for Asian Philanthropy and Society (CAPS)
Established in 2013 and working across more than 17 economies in Asia, the Centre for Asian Philanthropy and Society (CAPS) is a nonprofit organization committed to improving the quantity and quality of philanthropic and private giving throughout Asia. Our mission is to maximize private capital for public good, conducting research, advisory, convening and capacity building to engage philanthropists, foundations, family offices, corporates, government bodies, social sector organizations and experts on best practices, models, policies and strategies to facilitate private giving and social investment in the region. For more information, visit www.caps.org and LinkedIn.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
New medical plan combines cashless inpatient protection across Hong Kong and Mainland China with embedded outpatient and preventive care in Hong Kong
HONG KONG SAR - Media OutReach Newswire - 18 May 2026 - Bupa Hong Kong today announced the launch of Bupa Care Bridge Health Insurance Scheme, a new medical insurance solution designed to support Hong Kong residents whose lives increasingly span Hong Kong and Mainland China, and who are seeking affordable, practical health protection that covers both major medical events and everyday healthcare needs.
Bupa Hong Kong Launches Bupa Care Bridge as an Affordable Health Insurance Solution for Cross-border Living Cross‑border healthcare has become a growing reality for many Hong Kong people. In 2024 alone, Hong Kong residents made approximately 700,000 medical visits in Shenzhen, reflecting rising familiarity with receiving medical services across the border for efficiency, convenience and follow‑up care. At the same time, most continue to rely on Hong Kong for routine outpatient consultations, ongoing care and long‑term health management.
Bupa Care Bridge is designed around this reality. The scheme provides inpatient coverage across Hong Kong and Mainland China, while anchoring outpatient and preventive care in Hong Kong, where everyday healthcare is most frequently accessed. Designed with affordability in mind, the scheme offers two plan levels and flexible deductible options that allow customers to balance premium levels with the degree of protection they need, making the plan relevant to young adults, cross‑border professionals and retirees, including those managing healthcare costs over the long term.
Rather than positioning outpatient care as an optional add-on, Bupa Care Bridge embeds outpatient services within the medical plan itself, helping customers manage everyday healthcare costs more predictably while maintaining comprehensive inpatient protection.
Key features of Bupa Care Bridge include:
- Cashless inpatient care at designated hospitals, subject to pre-authorisation, with entitlement to standard private room accommodation in Mainland China and semi-private room accommodation in Hong Kong, providing greater certainty and comfort during hospital stays.
- Inpatient coverage across Mainland China or Greater China (Hong Kong, Macau, Mainland China and Taiwan), based on plan level, with worldwide coverage for emergency treatment to support major medical needs wherever they arise.
- Embedded outpatient care in Hong Kong, supporting everyday healthcare needs and follow-up care outside hospital settings (only applicable to Bupa Care Bridge Health Insurance Scheme Plus Plan). Covered services include general practitioner and specialist consultations, traditional Chinese medicine, physiotherapy, and X-ray and laboratory tests.
- Clear, predictable co‑payments for outpatient services, helping customers manage routine healthcare costs — with GP consultations from HK$40 per visit, specialist consultations from HK$60 per visit, and defined co‑payments for other outpatient services.
- Simplified underwriting with a streamlined health questionnaire, reducing friction at enrolment.
- Guaranteed lifetime renewal, providing long‑term certainty as healthcare needs evolve.
- Care coordination support for cross-border hospital treatment, including assistance with arranging transportation at discharge from hospital to home in Hong Kong and Shenzhen.
The scheme also supports preventive care, offering access to health check‑ups to encourage early detection and ongoing health monitoring, helping customers take a more proactive approach to managing their health rather than reacting only when serious illness occurs.
By combining affordable everyday outpatient care in Hong Kong with cashless inpatient protection across borders, Bupa Care Bridge supports both short‑term healthcare needs and longer‑term health planning in a more connected region.
Bupa Care Bridge Health Insurance Scheme is now available for enrolment. For more information, please visit www.bupa.com.hk/en/care-bridge.
Hashtag: #保柏香港 #BupaHongKong #跨境醫療 #CrossBorderHealthcare #GreaterChina
The issuer is solely responsible for the content of this announcement.
Bupa – An international health insurance specialist
Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 68 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia.
Bupa has been a health insurance specialist in Hong Kong since 1976, offering one-stop solutions across domestic and international health insurance, and healthcare services. Our comprehensive medical insurance schemes are tailored to meet individual needs, and we provide health solutions for companies of all sizes. We also have a team of registered nurses, health management professionals, and doctors who provide various expert healthcare support.
Our healthcare provision arm, Quality HealthCare Medical Services (QHMS), became part of Bupa in October 2013. QHMS offers Western Medicine, Traditional Chinese Medicine, Diagnostics & Imaging, Physiotherapy, Mental Health and Wellness services via a network of over 1,650 provider service points in Hong Kong.
For more information, visit www.bupa.com.hk/en/.
HONG KONG SAR - Media OutReach Newswire - 18 May 2026 - Bupa Hong Kong today announced the launch of Bupa Care Bridge Health Insurance Scheme, a new medical insurance solution designed to support Hong Kong residents whose lives increasingly span Hong Kong and Mainland China, and who are seeking affordable, practical health protection that covers both major medical events and everyday healthcare needs.
Bupa Hong Kong Launches Bupa Care Bridge as an Affordable Health Insurance Solution for Cross-border Living
Cross‑border healthcare has become a growing reality for many Hong Kong people. In 2024 alone, Hong Kong residents made approximately 700,000 medical visits in Shenzhen, reflecting rising familiarity with receiving medical services across the border for efficiency, convenience and follow‑up care. At the same time, most continue to rely on Hong Kong for routine outpatient consultations, ongoing care and long‑term health management.
Bupa Care Bridge is designed around this reality. The scheme provides inpatient coverage across Hong Kong and Mainland China, while anchoring outpatient and preventive care in Hong Kong, where everyday healthcare is most frequently accessed. Designed with affordability in mind, the scheme offers two plan levels and flexible deductible options that allow customers to balance premium levels with the degree of protection they need, making the plan relevant to young adults, cross‑border professionals and retirees, including those managing healthcare costs over the long term.
Rather than positioning outpatient care as an optional add-on, Bupa Care Bridge embeds outpatient services within the medical plan itself, helping customers manage everyday healthcare costs more predictably while maintaining comprehensive inpatient protection.
Key features of Bupa Care Bridge include:
- Cashless inpatient care at designated hospitals, subject to pre-authorisation, with entitlement to standard private room accommodation in Mainland China and semi-private room accommodation in Hong Kong, providing greater certainty and comfort during hospital stays.
- Inpatient coverage across Mainland China or Greater China (Hong Kong, Macau, Mainland China and Taiwan), based on plan level, with worldwide coverage for emergency treatment to support major medical needs wherever they arise.
- Embedded outpatient care in Hong Kong, supporting everyday healthcare needs and follow-up care outside hospital settings (only applicable to Bupa Care Bridge Health Insurance Scheme Plus Plan). Covered services include general practitioner and specialist consultations, traditional Chinese medicine, physiotherapy, and X-ray and laboratory tests.
- Clear, predictable co‑payments for outpatient services, helping customers manage routine healthcare costs — with GP consultations from HK$40 per visit, specialist consultations from HK$60 per visit, and defined co‑payments for other outpatient services.
- Simplified underwriting with a streamlined health questionnaire, reducing friction at enrolment.
- Guaranteed lifetime renewal, providing long‑term certainty as healthcare needs evolve.
- Care coordination support for cross-border hospital treatment, including assistance with arranging transportation at discharge from hospital to home in Hong Kong and Shenzhen.
The scheme also supports preventive care, offering access to health check‑ups to encourage early detection and ongoing health monitoring, helping customers take a more proactive approach to managing their health rather than reacting only when serious illness occurs.
By combining affordable everyday outpatient care in Hong Kong with cashless inpatient protection across borders, Bupa Care Bridge supports both short‑term healthcare needs and longer‑term health planning in a more connected region.
Bupa Care Bridge Health Insurance Scheme is now available for enrolment. For more information, please visit www.bupa.com.hk/en/care-bridge.
Hashtag: #保柏香港 #BupaHongKong #跨境醫療 #CrossBorderHealthcare #GreaterChina
The issuer is solely responsible for the content of this announcement.
Bupa – An international health insurance specialist
Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 68 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia.
Bupa has been a health insurance specialist in Hong Kong since 1976, offering one-stop solutions across domestic and international health insurance, and healthcare services. Our comprehensive medical insurance schemes are tailored to meet individual needs, and we provide health solutions for companies of all sizes. We also have a team of registered nurses, health management professionals, and doctors who provide various expert healthcare support.
Our healthcare provision arm, Quality HealthCare Medical Services (QHMS), became part of Bupa in October 2013. QHMS offers Western Medicine, Traditional Chinese Medicine, Diagnostics & Imaging, Physiotherapy, Mental Health and Wellness services via a network of over 1,650 provider service points in Hong Kong.
For more information, visit www.bupa.com.hk/en/.
** This press release is distributed by Media OutReach Newswire through automated distribution system, for which the client assumes full responsibility. **
